Febuxostat-Induced Acute Liver Injury

被引：52

作者：

Bohm, Matt ^{[1
]}

Vuppalanchi, Raj ^{[1
]}

Chalasani, Naga ^{[1
]}

机构：

[1] Indiana Univ Sch Med, Dept Med, 702 Rotary Bldg,Suite 225, Indianapolis, IN 46202 USA

来源：

HEPATOLOGY | 2016年 / 63卷 / 03期

关键词：

GOUT; HYPERURICEMIA; ALLOPURINOL;

D O I：

10.1002/hep.28403

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

收藏

页码：1047 / 1049

页数：3

相关论文

共 4 条

[1]

Febuxostat compared with allopurinol in patients with hyperuricemia and gout [J].

Becker, MA ;

Schumacher, HR ;

Wortmann, RL ;

MacDonald, PA ;

Eustace, D ;

Palo, WA ;

Streit, J ;

Joseph-Ridge, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2450-2461

[2]

Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout [J].

Becker, Michael A. ;

Schumacher, H. Ralph ;

MacDonald, Patricia A. ;

Lloyd, Eric ;

Lademacher, Christopher .

JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) :1273-1282

[3]

Febuxostat: A selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout [J].

Bruce, Susan P. .

ANNALS OF PHARMACOTHERAPY, 2006, 40 (12) :2187-2194

[4]

Drug-Induced Liver Injury Network (DILIN) Prospective Study Rationale, Design and Conduct [J].

Fontana, Robert J. ;

Watkins, Paul B. ;

Bonkovsky, Herbert L. ;

Chalasani, Naga ;

Davern, Timothy ;

Serrano, Jose ;

Rochon, James .

DRUG SAFETY, 2009, 32 (01) :55-68